1. The role of cytotoxic T-lymphocytes in the prevention and immune surveillance of tumors— lessons from normal and immunodeficient mice

   • IM Svane
   • M Boesen
   • A-M Engel

   Review 01 December 1999 Pages: 223 - 238

2. Distribution of 2-chloro-2′-deoxyadenosine, 2-chloro-2′-arabino-fluoro-2′-deoxyadenosine, Fludarabine and Cytarabine in mice: a whole-body autoradiography study

   • Synnöve Lindemalm
   • Jan Liliemark
   • Freidoun Albertioni

   Original Paper 01 December 1999 Pages: 239 - 244

3. Reduced bone marrow stem cell pool and progenitor mobilisation in multiple myeloma after melphalan treatment

   • L Meldgaard Knudsen
   • T Rasmussen
   • HE Johnsen

   Original Paper 01 December 1999 Pages: 245 - 254

4. Long-term results after combined modality treatment for non-metastatic osteosarcoma

   • J Aparicio
   • A Segura
   • B Munárriz

   Original Paper 01 December 1999 Pages: 255 - 260

5. Phase II protocol for the evaluation of new treatments in patients with advanced gastric carcinoma: results of ECOG 5282

   • Y Novik
   • LM Ryan
   • A Schutt

   Original Paper 01 December 1999 Pages: 261 - 266

6. Synergistic antitumour effects of chemo-immunotherapy with an oxazaphosphorine drug and IL-2-secreting cells in a mouse colon cancer model

   • H Kusnierczyk
   • E Pajtasz-Piasecka
   • C Radzikowski

   Original Paper 01 December 1999 Pages: 267 - 278

7. Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination

   • Edward A Stadtmauer
   • Donald E Tsai
   • Leslie E Silberstein

   Original Paper 01 December 1999 Pages: 279 - 288

8. Cytokine expression in B-CLL in relation to disease progression andin vitro activation

   • M Aguilar-Santelises
   • D Gigliotti
   • M Jondal

   Original Paper 01 December 1999 Pages: 289 - 295